Positron emission tomography: brain tumors and lung cancer.


Journal Article (Review)

F-18 fluorodeoxyglucose positron emission tomography is a uniquely powerful diagnostic tool that noninvasively provides information that is critical to appropriate clinical management of patients with non-small cell lung cancer. Not only does the functional information provided by PET complement and clarify the anatomic information supplied by CT and MR imaging, but the superior sensitivity and negative predictive value of PET allow for improved accuracy in diagnosis, prognosis, staging, and monitoring the effects of treatment. With better information at their disposal, clinicians and patients are able to make better-informed decisions, contributing to more appropriate and more cost-effective medical care. Truly, FDG-PET has earned its place as the new standard of care in imaging non-small cell lung cancer.

Full Text

Duke Authors

Cited Authors

  • Hagge, RJ; Wong, TZ; Coleman, RE

Published Date

  • September 2001

Published In

Volume / Issue

  • 39 / 5

Start / End Page

  • 871 - 881

PubMed ID

  • 11587059

Pubmed Central ID

  • 11587059

Electronic International Standard Serial Number (EISSN)

  • 1557-8275

International Standard Serial Number (ISSN)

  • 0033-8389

Digital Object Identifier (DOI)

  • 10.1016/s0033-8389(05)70318-3


  • eng